Skip to main content
Clinical Trials/IRCT2017061234482N1
IRCT2017061234482N1RecruitingPhase 3

A study of the effect of melatonin on prevention of delirium in Intensive Care Unite (ICU) inpatients

Vice chancellor for research, Kermanshah University of Medical Sciences0 sites92 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
92

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 100 years (—)
Sex
All

Inclusion Criteria

  • Ag 18 or above; admitted in ICU; Consciousness
  • Exclusion criteria: Dementia; Critically ill patients; having contraindication of melatonin use; being a current user of melatonin

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Kermanshah University of Medical Sciences

Similar Trials